03 Profile
Who Professor Dmitry Pshezhetskiy is
Professor Dmitry Pshezhetskiy is a Professorial Research Fellow at the University of East Anglia's Norwich Medical School. His research covers cancer molecular and cell biology, epigenetic diagnostic markers and nanoparticle-based cancer therapies.
He has an MSc from Lomonosov Moscow State University. He joined Imperial College London in 2006 as a Research Fellow and head of its Tumour Microenvironment and Chemotherapy group. He has held an Honorary Senior Lectureship at Norwich Medical School since April 2012.
He was named as lead researcher on UEA and Oxford BioDynamics work on a blood test for ME/CFS, reported as 96% accurate. He has also been quoted on a combined PSA and epigenetic blood test for prostate cancer. In the press he has argued that ME/CFS patients have often gone undiagnosed or misdiagnosed for years because no definitive test exists.
He has said a diagnosis could lead to earlier support and better management.
Notable achievements
- 01
Lead researcher on the UEA and Oxford BioDynamics programme that applied EpiSwitch 3D genomic profiling to ME/CFS, producing a blood-based diagnostic with 96% accuracy, published in the Journal of Translational Medicine in 2025. Source ↗
- 02
Quoted by UEA as lead researcher on the ME/CFS blood test. Source ↗
- 03
UEA team piloted the Prostate Screening EpiSwitch (PSE) blood test, which combines PSA with an epigenetic test and was reported as 94% accurate, in 147 patients. Source ↗
- 04
Co-developer of a patented nanoparticle system for cancer treatment (WO/2018/115835). Source ↗
- 05
Won the AstraZeneca Start-up Challenge and the 2025 Best Paper of the Year Award from the journal Cancers, according to his UEA research portal profile. Source ↗
- 06
Member of the editorial board of several journals, including the American Journal of Cancer Research, Cancers and Frontiers in Oncology. Source ↗



